Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > GUD implied promises on past Paladin success
View:
Post by Chianchin on Mar 27, 2023 5:12pm

GUD implied promises on past Paladin success

Regretably the Paladin Jeene did show up and the lamp went dark. The share price capitulation will continue as I "suspect" GUD MNGT has come to relize that keeping GUD share price above $5 has cost shareholders fortunes and is n longer sustainablle to overpay. What may come next? Firs all the promoters are running broke and no one would take ther advise to buy more of GUD after losing fortunes for 10 years. When and if the share price come arround $2 MNGT may go foer the exit door and a new capable MNGT takes over  and or some big wheel may take GUD private. One billion in cash and 10  later there are no more promises. I am surprised that MNGT and the BOD are hanging arround still. Meir knew well the faith to come for the limping knight. No one want to beleive him. 
Out for now
Be the first to comment on this post
Knight Therapeutics Inc